The history of pneumococcal conjugate vaccine development: dose selection.
about
Why might regional vaccinology networks fail? The case of the Dutch-Nordic ConsortiumPneumococcal Capsules and Their Types: Past, Present, and FutureStreptococcus pneumoniae Enhances Human Respiratory Syncytial Virus Infection In Vitro and In Vivo.Differential B-cell memory around the 11-month booster in children vaccinated with a 10- or 13-valent pneumococcal conjugate vaccine.A Synthetic Virus-Like Particle Streptococcal Vaccine Candidate Using B-Cell Epitopes from the Proline-Rich Region of Pneumococcal Surface Protein A.Theory and strategy for Pneumococcal vaccines in the elderly.Anti-Infectious Human Vaccination in Historical Perspective.Direct and indirect impact of 10-valent pneumococcal conjugate vaccine introduction on pneumonia hospitalizations and economic burden in all age-groups in Brazil: A time-series analysis.Development of pneumococcal vaccines over the last 10 years.Principles of vaccine potency assays.Bacterial Vaccine Antigen Discovery in the Reverse Vaccinology 2.0 Era: Progress and Challenges
P2860
Q26744029-90FBC1BD-95CD-447D-B462-9934A9083AFDQ27006887-E86F139E-83D7-46F8-A771-E18C79D051ACQ35603103-4FEEE60A-3FC2-4C09-9A79-6C757530DF96Q35855954-47F548F6-FD52-44BA-97A3-897978BF1E2BQ36409520-10606752-7759-449C-AD2A-2DAB69B16CBAQ37309215-189F44A0-5C66-482F-B280-3FE9313D5EDCQ40129444-84AA4A30-CAEF-4119-8856-485C084CBD7AQ41573156-BC6AB93F-FC69-4A6F-B1A7-6CE3BF9D2555Q47658958-F9DA0C34-8DB0-4497-AF04-F0A4D5581A7BQ50047834-1683895F-E5DD-4434-9BDB-354E4B05703BQ57817461-FBC846ED-8E3F-4306-B67D-7881914ED708
P2860
The history of pneumococcal conjugate vaccine development: dose selection.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The history of pneumococcal conjugate vaccine development: dose selection.
@en
type
label
The history of pneumococcal conjugate vaccine development: dose selection.
@en
prefLabel
The history of pneumococcal conjugate vaccine development: dose selection.
@en
P2093
P2860
P1476
The history of pneumococcal conjugate vaccine development: dose selection.
@en
P2093
Carla C A M Peeters
Germie P J M van den Dobbelsteen
Jan T Poolman
P2860
P304
P356
10.1586/14760584.2013.852475
P577
2013-12-01T00:00:00Z